The latest news in renal cancer
Cryotherapy could be a game changer for patients with early-stage kidney cancer
Today, small kidney tumours are most often treated with a minor operation in which all…
Browsing: Kidney Cancer
Study identifies target for disease hyper progression after immunotherapy in kidney cancer
Researchers at The University of Texas MD Anderson Cancer Centre, USA, have found that renal…
Additional testing can improve kidney cancer diagnosis
A study from the University of Michigan Health Rogel Cancer Centre and Department of Pathology,…
Molecular markers and risk models guide precision care in liver cancer surgery
Hyper-progression recurrence (HPR) after surgery for hepatocellular carcinoma (HCC) is a particularly aggressive relapse pattern…
ESMO 2025: Dual targeted therapy shows promise in previously treated advanced kidney cancer
Results from a trial presented at ESMO 205 have shown that a targeted therapy combination improved…
Kidney cancer cases are projected to double by 2050
Modifiable risk factors such as obesity, smoking, lack of exercise, diabetes, and hypertension are projected…
β-catenin/TCF4 is required for DDX17-induced epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma
This study focuses on exploring the functional roles and molecular mechanisms of DDX17 in HCC metastasis.…
Immunotherapy–targeted therapy combinations show promise in rare kidney cancer subtypes
New Meta-analysis Backs Efficacy in nccRCC A new systematic review and meta-analysis have reinforced the…
Hepatocellular carcinoma and the role of liver transplantation
Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, accounting for the majority…
Outcomes for advanced hepatocellular carcinoma with pulmonary metastasis: Surgical vs. immunotherapy
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related deaths worldwide, with over 70% of…